Back to User profile » Dr Makiko Yomota

Papers published by Dr Makiko Yomota:

Original Research

Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study

Iso H, Yomota M, Shirakura Y, Yoshinaga T, Kawai S, Narita K, Seike M, Hosomi Y

OncoTargets and Therapy 2025, 18:379-387

Published Date: 19 March 2025

Case report

Case Report: Structurally Rare EML4-ALK Identified by Next Generation Sequencing in a Patient with NSCLC with Bilateral Ovarian Metastases

Maruta R, Sadato D, Yomota M, Gomikawa R, Motoi T, Sato T, Kino N, Kobayashi M, Hosomi Y

OncoTargets and Therapy 2024, 17:777-783

Published Date: 23 September 2024

Case report

Acquisition of T790M resistance mutation in a patient with advanced adenocarcinoma harboring uncommon EGFR mutations: a case report and literature review

Hakozaki T, Yomota M

OncoTargets and Therapy 2019, 12:745-748

Published Date: 22 January 2019

Clinical Trial Report

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1

Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T

OncoTargets and Therapy 2016, 9:5287-5295

Published Date: 24 August 2016